Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to assess the efficacy of filgotinib, lanraplenib, and tirabrutinib in adults with active Sjogren's Syndrome (SjS).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gilead Sciences
Collaborators
NCT01425892 · Sjogren's Syndrome, Salivary Gland, and more
NCT07526350 · Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies, and more
NCT07413341 · Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome (SS), and more
NCT04402086 · Rheumatic Diseases, Adult Onset Still Disease, and more
NCT07301892 · Rheumatoid Arthritis (RA, Osteoporosis, and more
AARR Arizona Arthritis & Rheumatology Research
Mesa, Arizona
AARR Arizona Arthritis & Rheumatology Research
Phoenix, Arizona
Medvin Clinical Research
Covina, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions